Tizanidine Hydrochloride Orally Disintegrating Tablets(Sichuan Credit Pharma)

盐酸替扎尼定口腔崩解片（四川科瑞德制药）

Report date: 2025/07/04 15:11:29

Base Information

Drug NameTizanidine Hydrochloride Orally Disintegrating Tablets(Sichuan Credit Pharma)
Drug Alias NameTizanidinum替扎尼定Tizanidine盐酸替扎尼定口腔崩解片（改良型）Tizanidina
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 agonists
TargetsAdrenergic receptors alpha-2
Therapy Area/IndicationsPainMyotoniaMuscle Spasticity
Global Approved IndicationsPainMyotoniaMuscle Spasticity
Approved Indications in ChinaPainMyotoniaMuscle Spasticity
Original Approved Country/TerritoryMainland China
Original Approved Date2014/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSichuan Credit Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSichuan Credit Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPainMyotoniaMuscle Spasticity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG